Literature DB >> 16275660

Identification of VCP/p97, carboxyl terminus of Hsp70-interacting protein (CHIP), and amphiphysin II interaction partners using membrane-based human proteome arrays.

Gerlinde Grelle1, Susanne Kostka, Albrecht Otto, Birgit Kersten, Klaus F Genser, Eva-Christina Müller, Stephanie Wälter, Annett Böddrich, Ulrich Stelzl, Christian Hänig, Rudolf Volkmer-Engert, Christiane Landgraf, Simon Alberti, Jörg Höhfeld, Martin Strödicke, Erich E Wanker.   

Abstract

Proteins mediate their biological function through interactions with other proteins. Therefore, the systematic identification and characterization of protein-protein interactions have become a powerful proteomic strategy to understand protein function and comprehensive cellular regulatory networks. For the screening of valosin-containing protein, carboxyl terminus of Hsp70-interacting protein (CHIP), and amphiphysin II interaction partners, we utilized a membrane-based array technology that allows the identification of human protein-protein interactions with crude bacterial cell extracts. Many novel interaction pairs such as valosin-containing protein/autocrine motility factor receptor, CHIP/caytaxin, or amphiphysin II/DLP4 were identified and subsequently confirmed by pull-down, two-hybrid and co-immunoprecipitation experiments. In addition, assays were performed to validate the interactions functionally. CHIP e.g. was found to efficiently polyubiquitinate caytaxin in vitro, suggesting that it might influence caytaxin degradation in vivo. Using peptide arrays, we also identified the binding motifs in the proteins DLP4, XRCC4, and fructose-1,6-bisphosphatase, which are crucial for the association with the Src homology 3 domain of amphiphysin II. Together these studies indicate that our human proteome array technology permits the identification of protein-protein interactions that are functionally involved in neurodegenerative disease processes, the degradation of protein substrates, and the transport of membrane vesicles.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16275660     DOI: 10.1074/mcp.M500198-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  18 in total

1.  Induction of cell proliferation, clonogenicity and cell accumulation in S phase as a consequence of human UBE2Q1 overexpression.

Authors:  Mohammad Ali Fahmidehkar; Sayed Mohammad Shafiee; Ebrahim Eftekhar; Laleh Mahbudi; Atefeh Seghatoleslam
Journal:  Oncol Lett       Date:  2016-07-13       Impact factor: 2.967

2.  Mammalian diseases of phosphatidylinositol transfer proteins and their homologs.

Authors:  Aaron H Nile; Vytas A Bankaitis; Aby Grabon
Journal:  Clin Lipidol       Date:  2010-12-01

3.  A caspase cleaved form of tau is preferentially degraded through the autophagy pathway.

Authors:  Philip J Dolan; Gail V W Johnson
Journal:  J Biol Chem       Date:  2010-05-13       Impact factor: 5.157

Review 4.  Animal models of dystonia: Lessons from a mutant rat.

Authors:  Mark S LeDoux
Journal:  Neurobiol Dis       Date:  2010-11-21       Impact factor: 5.996

5.  Discovery of peptidylarginine deiminase-4 substrates by protein array: antagonistic citrullination and methylation of human ribosomal protein S2.

Authors:  Qin Guo; Mark T Bedford; Walter Fast
Journal:  Mol Biosyst       Date:  2011-05-16

6.  The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins.

Authors:  Chad A Dickey; Adeela Kamal; Karen Lundgren; Natalia Klosak; Rachel M Bailey; Judith Dunmore; Peter Ash; Sareh Shoraka; Jelena Zlatkovic; Christopher B Eckman; Cam Patterson; Dennis W Dickson; N Stanley Nahman; Michael Hutton; Francis Burrows; Leonard Petrucelli
Journal:  J Clin Invest       Date:  2007-02-15       Impact factor: 14.808

7.  CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model.

Authors:  Hiroaki Adachi; Masahiro Waza; Keisuke Tokui; Masahisa Katsuno; Makoto Minamiyama; Fumiaki Tanaka; Manabu Doyu; Gen Sobue
Journal:  J Neurosci       Date:  2007-05-09       Impact factor: 6.167

8.  Upregulated expression of ubiquitin-conjugating enzyme E2Q1 (UBE2Q1) is associated with enhanced cell proliferation and poor prognosis in human hapatocellular carcinoma.

Authors:  Renan Chang; Lixian Wei; Yuhua Lu; Xiaopeng Cui; Cuihua Lu; Luoliang Liu; Dawei Jiang; YiCheng Xiong; Gang Wang; Chunhua Wan; Haixin Qian
Journal:  J Mol Histol       Date:  2014-10-14       Impact factor: 2.611

Review 9.  Amphiphysin 2 (BIN1) in physiology and diseases.

Authors:  Ivana Prokic; Belinda S Cowling; Jocelyn Laporte
Journal:  J Mol Med (Berl)       Date:  2014-03-05       Impact factor: 4.599

10.  The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.

Authors:  Umesh K Jinwal; John Koren; Sergiy I Borysov; Andreas B Schmid; Jose F Abisambra; Laura J Blair; Amelia G Johnson; Jeffrey R Jones; Cody L Shults; John C O'Leary; Ying Jin; Johannes Buchner; Marc B Cox; Chad A Dickey
Journal:  J Neurosci       Date:  2010-01-13       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.